Results 221 to 230 of about 1,113,334 (249)
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
When the Money Stops: A Safety-First Plan for Paused Clinical Trials. [PDF]
Smith D.
europepmc +1 more source
FIREX mission requirements document for nonrenewable resources
Timothy H. Dixon, F. Carsey
openalex +1 more source
Case of a 35‐Year‐Old Man With Pain With Sneezing and Leg Weakness Causing Collapse
ABSTRACT This case details a 35‐year‐old man with no past medical history who presents with acute paraparesis and urinary retention in the setting of progressive paresthesias and weakness of his lower and upper extremities over several months. He was found to have longitudinally extensive transverse myelitis involving the cervical to mid‐thoracic cord ...
Joey Hsu +3 more
wiley +1 more source
A Checklist for Involving Patients in Educational Activities. [PDF]
Young M, Kline C, Towle A.
europepmc +1 more source
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin +12 more
wiley +1 more source
Research Trends and Insights Regarding MicroRNAs in Psoriasis: A Comprehensive Analysis. [PDF]
Örs I, Cosansu NC, Solak B.
europepmc +1 more source
Conceptos introductorios al estudio de la información documental (J. A. Moreiro González)
Arturo Martín Vega
openalex +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
What guidance exists to support remote consultations in sexual and reproductive health services? A review of the policy and practice literature. [PDF]
Spurway C +11 more
europepmc +1 more source

